| Application no. and date | 19847964.4 (espacenet) (Federated) (European Patent Register), 20190806 | | Patent/reg. no. and date | DK/EP 3833690, 20240327 | | Publication date | 20210616 | | Priority no. and date | US 201862716356 P, 20180808 | | EP pub. no. and date |
EP 3833690 20210616 | | Effective date | | | Applicant/owner | ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Building 15, Lane 1000, Zhangheng Road,
Pudong New Area
Shanghai 201203, CN | | Applicant ref. no. | | | Inventor | TIAN, Wenzhi, Room 502, Building 8, No. 1043, Halei Road Pudong
District
Shanghai 201203, CN,
LI, Song, Room 502, Building 8, No. 1043, Halei Road Pudong
District
Shanghai 201203, CN | | Representative | | | Opponent | | | IPC Class | A61K 39/39 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C07K 16/46 (2006.01) | | Title | RECOMBINANT BIFUNCTIONAL PROTEIN TARGETING CD47 AND HER2 | | Int. application no. | CN2019099530 | | Int. publication no. | WO2020029982 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
